Cure Duchenne Hosts Accelerated Access Webinar with the FDA
15:22 EST 14 Feb 2013 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
CureDuchenne,
a nonprofit that raises awareness and funds research to find a cure for
Duchenne muscular dystrophy, will host a webinar
on accelerated access for drug approvals with the Food
and Drug Administration (FDA) o...
Other Sources for this Article
CureDuchenne
Karen Harley, 949-872-2552
More From BioPortfolio on "Cure Duchenne Hosts Accelerated Access Webinar with the FDA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
